Author

D. G. Stover

Observed name: D. Stover

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University

Observed institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University

OpenAlex ID: A5126525138

PS5-06-07: A case report of veno-occlusive disease (VOD) in a patient with metastatic triple-negative breast cancer receiving trastuzumab deruxtecan

2026 · K. N. Koehler, K. Noce, et al. · Clinical Cancer Research

Abstract PS4-01-15: Acute and Early Circulating Tumor DNA Dynamics in Metastatic Triple-Negative Breast Cancer Targeted Therapy Phase Ib/II Clinical Trials

2026 · B. To, V. Prasath, et al. · Clinical Cancer Research

PS5-06-09: Immunotherapy induced Kikuchi Fujimoto (Histiocytic Necrotizing Lymphadenitis): A Rare Immune Related Adverse Event

2026 · B. To, V. Prasath, et al. · Clinical Cancer Research

Abstract PS4-03-03: Age-driven genomic differences in breast cancer: relevance for PI3K-pathway

2026 · N. Lopetegui-Lia, A. Davenport, et al. · Clinical Cancer Research

Abstract PS4-01-06: Genomic alterations in young adults compared to average-onset patients with breast cancer

2026 · N. Lopetegui-Lia, A. Davenport, et al. · Clinical Cancer Research

Abstract PS2-08-17: Prevalence and clinical significance of exon 6 ESR1 gene fusions in advanced breast cancer after disease progression on aromatase inhibitors

2026 · S. A. Wander, D. G. Stover, et al. · Clinical Cancer Research

Abstract PS5-03-11: Combinatorial EZH2 Inhibition and Dopamine D1 Agonism Suppresses Pro-Inflammatory Monocytes and TNBC Tumor Progression

2026 · R. Shukla, K. Ormiston, et al. · Clinical Cancer Research

Abstract PS2-09-20: Circulating Tumor DNA Dynamics and Anatomical Patterns of Relapse Following Curative Therapy in Early-Stage Breast Cancer

2026 · D. Stover, B. Dwivedi, et al. · Clinical Cancer Research

Abstract PS2-07-27: Qutils: open-source image-based infiltrating immune cell detection and outcomes in calgb 40502, calgb 40603, and calgb 40601 phase iii breast cancer clinical trials

2026 · M. Vater, R. Salgado, et al. · Clinical Cancer Research

Abstract PS2-07-29: Digital Histology Models Predict Chemotherapy Benefit in Randomized Adjuvant Trials and Real-World Cohorts

2026 · F. M. Howard, S. Kochanny, et al. · Clinical Cancer Research

Abstract PS3-03-19: Single Cell Proteomic Phenotyping Reveals Mitigation of Abrupt Involution-Induced Alteration in Mammary Epithelium Upon Tamoxifen Treatment

2026 · S. Majumder, K. G. Gray, et al. · Clinical Cancer Research

Abstract PS2-09-15: Application of CNSigs, An R Package for the Identification of Copy Number Mutational Signatures, in Early and Advanced Breast Cancer

2026 · S. Striker, D. Tallman, et al. · Clinical Cancer Research

Abstract PS2-09-22: The Impact of Breast Cancer Histology and Tumor Molecular Subtype on Nodal Positivity

2026 · S. Myers, Y. Gokun, et al. · Clinical Cancer Research

Abstract PS5-10-01: Misinformation about breast cancer treatment on social media: Implications for engagement with patients and social media

2026 · M. Gatti-Mays, K. Koehler, et al. · Clinical Cancer Research

Works count: 14

Citation count:

H-index:

I10-index: